High disease impact of myotonic dystrophy type 2 on physical and mental functioning

Journal of Neurology

Volumn 258, Issue 10, 2011, Pages 1820-1826

  Tieleman, Alide A ^a,b   Jenks, Kathleen M ^a,b   Kalkman, Joke S ^a,b   Borm, George ^a,b   Van Engelen, Baziel G M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Fatigue; Health status; Myotonic dystrophy type 1; Myotonic dystrophy type 2; Pain

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MALE; MENTAL FUNCTION; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; PAIN; PRIORITY JOURNAL; SHORT FORM 36; SOCIAL STATUS;

ADULT; AGED; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MYOTONIC DISORDERS; PAIN; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 80054748666     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6027-8     Document Type: Article

References (30)

1. Harper PS, van Engelen BGM, Eymard B et al (2004) Myotonic dystrophy: present management, future therapy. Oxford University Press, New York
2. G Meola V Sansone 2007 Cerebral involvement in myotonic dystrophies Muscle Nerve 6 294 306 10.1002/mus.20800 (Pubitemid 47326007)
3. AA Tieleman J van Vliet JB Jansen, et al. 2008 Gastrointestinal involvement is frequent in myotonic dystrophy type 2 Neuromuscul Disord 18 646 649 18602828 10.1016/j.nmd.2008.05.010
4. CL Liquori K Ricker ML Moseley, et al. 2001 Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9 Science 293 864 867 11486088 10.1126/science.1062125 1:CAS:528:DC%2BD3MXlvVKktbc%3D (Pubitemid 32743976)
5. B Udd G Meola R Krahe, et al. 2006 140th ENMC international workshop: myotonic dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management Neuromuscul Disord 16 403 413 16684600 10.1016/j.nmd.2006.03.010 1:STN:280:DC%2BD28zmvVShtw%3D%3D (Pubitemid 43884790)
6. A George C Schneider-Gold S Zier, et al. 2004 Musculoskeletal pain in patients with myotonic dystrophy type 2 Arch Neurol 61 1938 1942 15596616 10.1001/archneur.61.12.1938 (Pubitemid 39612956)
7. C Turner D Hilton-Jones 2010 The myotonic dystrophies: diagnosis and management J Neurol Neurosurg Psychiatry 81 358 367 20176601 10.1136/jnnp.2008.158261
8. MP Jensen AJ Hoffman BL Stoelb, et al. 2008 Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy Arch Phys Med Rehabil 89 320 328 18226657 10.1016/j.apmr.2007.08.153
9. MP Jensen RT Abresch GT Carter, et al. 2005 Chronic pain in persons with neuromuscular disease Arch Phys Med Rehabil 86 1155 1163 15954054 10.1016/j.apmr.2004.11.028 (Pubitemid 40797769)
10. J Trip J de Vries G Drost, et al. 2009 Health status in non-dystrophic myotonias: close relation with pain and fatigue J Neurol 256 939 947 19252786 10.1007/s00415-009-5049-y 1:STN:280:DC%2BD1MvivFartg%3D%3D
11. JS Kalkman ML Schillings SP van der Werf, et al. 2005 Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I J Neurol Neurosurg Psychiatry 76 1406 1409 16170086 10.1136/jnnp.2004.050005 1:STN:280:DC%2BD2MvpslyhsA%3D%3D (Pubitemid 41360981)
12. De Vries J (2001) Quality of life assessment. In: Vingerhoets AJJM (ed) Assessment in behavioral medicine. Brunner-Routledge, Hove, pp 353-370
13. AK Wagner B Gandek NK Aaronson, et al. 1998 Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA project. International quality of life assessment J Clin Epidemiol 51 925 932 9817109 10.1016/S0895-4356(98)00083-3 1:STN:280:DyaK1M%2FjtF2quw%3D%3D (Pubitemid 28527147)
14. B Gandek JE Ware Jr 1998 Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach. International quality of life assessment J Clin Epidemiol 51 953 959 9817112 10.1016/S0895-4356(98)00086-9 1:STN:280:DyaK1M%2Fjt1SjsA%3D%3D (Pubitemid 28527150)
15. NK Aaronson M Muller PD Cohen, et al. 1998 Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations J Clin Epidemiol 51 1055 1068 9817123 10.1016/S0895-4356(98)00097-3 1:STN:280:DyaK1M%2Fjt1SisQ%3D%3D (Pubitemid 28527161)
16. BG van Engelen H van Veenendaal PA van Doorn, et al. 2007 The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data Neuromuscul Disord 17 33 37 17141501 10.1016/j.nmd.2006.09.017 (Pubitemid 46186008)
17. JE Ware Jr CD Sherbourne 1992 The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection Med Care 30 473 483 1593914 10.1097/00005650-199206000-00002
18. R Sadjadi MR Rose Muscle Study Group 2010 What determines quality of life in inclusion body myositis? J Neurol Neurosurg Psychiatry 81 1164 1166 20601666 10.1136/jnnp.2009.183863 1:STN:280:DC%2BC3cfkslersg%3D%3D
19. ML Hagemans AC Janssens LP Winkel, et al. 2004 Late-onset Pompe disease primarily affects quality of life in physical health domains Neurology 63 1688 1692 15534256 1:STN:280:DC%2BD2crmt1eguw%3D%3D (Pubitemid 39507589)
20. K Vanderiet H Adriaensen H Carton, et al. 1987 The McGill pain questionnaire constructed for the Dutch language (MPQ-DV). Preliminary data concerning reliability and validity Pain 30 395 408 3670884 10.1016/0304- 3959(87)90027-3 1:STN:280:DyaL1c%2FktVSktQ%3D%3D (Pubitemid 18028136)
21. WA Van der Kloot RA Oostendorp J van der Meij, et al. 1995 The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire Ned Tijdschr Geneeskd 139 669 673 7723868
22. JH Vercoulen CM Swanink JF Fennis, et al. 1994 Dimensional assessment of chronic fatigue syndrome J Psychosom Res 38 383 392 7965927 10.1016/0022- 3999(94)90099-X 1:STN:280:DyaK2M%2FlsFeitQ%3D%3D (Pubitemid 24188056)
23. JB Prins G Bleijenberg E Bazelmans, et al. 2001 Cognitive behavior therapy for chronic fatigue syndrome: a multicentre randomised controlled trial Lancet 17 841 847 10.1016/S0140-6736(00)04198-2 (Pubitemid 32239369)
24. ISJ Merkies PIM Schmitz FGA van der Meche, et al. 2002 Quality of life complements traditional outcome measures in immune-mediated polyneuropathies Neurology 59 84 91 12105312 1:STN:280:DC%2BD38zmtVOltQ%3D%3D (Pubitemid 34742799)
25. CS Carver MF Scheier 2000 Scaling back goals and recalibration of the affect system are processes in normal adaptive self-regulation: understanding 'response shift' phenomena Soc Sci Med 50 1715 1722 10798327 10.1016/S0277-9536(99)00412-8 1:STN:280:DC%2BD3c3ls1Wrtw%3D%3D (Pubitemid 30155501)
26. GI Kempen J Ormel EI Brilman, et al. 1997 Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life Am J Public Health 87 38 44 9065224 10.2105/AJPH.87.1.38 1:STN:280:DyaK2s7ovVKqug%3D%3D (Pubitemid 27069106)
27. G Meola V Sansone D Perani, et al. 2003 Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2) Neuromuscul Disord 13 813 821 14678804 10.1016/S0960-8966(03)00137-8 1:STN:280:DC%2BD3srpslGlsg%3D%3D (Pubitemid 37532731)
28. G Meola V Sansone D Perani, et al. 1999 Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy Neurology 53 1042 1050 10496264 1:STN:280:DyaK1MvisVGrsQ%3D%3D (Pubitemid 29442121)
29. G Meola V Sansone 2007 Cerebral involvement in myotonic dystrophies Muscle Nerve 36 294 306 17486579 10.1002/mus.20800 1:CAS:528:DC%2BD2sXhtVCqs7nJ (Pubitemid 47326007)
30. C Jenkinson 1999 Comparison of UK and US methods for weighting and scoring the SF-36 summary measures J Public Health Med 21 372 376 11469357 10.1093/pubmed/21.4.372 1:STN:280:DC%2BD3MvhvVKgsA%3D%3D (Pubitemid 30018964)